Asbestos induces activator protein-1 transactivation in transgenic mice

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1884-1889

  Ding, Min ^a   Dong, Zigang ^b   Chen, Fei ^a   Pack, Donna ^a   Ma, Wei Ya ^b   Ye, Jianping ^a   Shi, Xianglin ^a   Castranova, Vince ^a   Vallyathan, Val ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASBESTOS; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRONCHUS CANCER; CELL PROLIFERATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ASBESTOS; ASBESTOS, CROCIDOLITE; ASPIRIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOGENS; CELLS, CULTURED; ENZYME ACTIVATION; GENES, REPORTER; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

EID: 0033561737     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Mossman, B. T., and Gee, J. B. Asbestos-related diseases [see comments]. N. Engl. J. Med., 320: 1721-1730, 1989.
2. Petruska, J. M., Marsh, J., Bergeron, M., and Mossman, B. T. Brief inhalation of asbestos compromises superoxide production in cells from bronchoalveolar lavage. Am. J. Respir. Cell Mol. Biol., 2: 129-136, 1990.
3. 3+]. Arch. Biochem. Biophys., 298: 646-650, 1992.
4. Dong, H., Buard, A., Renier, A., Levy, F., Saint-Etienne, L., and Jaurand, M. C. Role of oxygen derivatives in the cytotoxicity and DNA damage produced by asbestos on rat pleural mesothelial cells in vitro. Carcinogenesis (Lond.), 15: 1251-1255, 1994.
5. Schapira, R. M., Ghio, A. J., Effros, R. M., Morrisey, J., Dawson, C. A., and Hacker, A. D. Hydroxyl radicals are formed in the rat lung after asbestos instillation in vivo. Am. J. Respir. Cell Mol. Biol., 10: 573-579, 1994.
6. Vallyathan, V., and Shi, X. The role of oxygen free radicals in occupational and environmental lung diseases. Environ. Health Perspect., 105 (Suppl. 1): 165-177, 1997.
7. Heintz, N. H., Janssen, Y. M., and Mossman, B. T. Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA, 90: 3299-3303, 1993.
8. Janssen, Y. M., Heintz, N. H., and Mossman, B. T. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res., 55: 2085-2089, 1995.
9. Mishra, A., Liu, J. Y., Brody, A. R., and Morris, G. F. Inhaled asbestos fibers induce p53 expression in the rat lung. Am. J. Respir. Cell Mol. Biol., 16: 479-485, 1997.
10. Marsh, J. P., and Mossman, B. T. Role of asbestos and active oxygen species in activation and expression of ornithine decarboxylase in hamster tracheal epithelial cells. Cancer Res., 51: 167-173, 1991.
11. Simeonova, P. P., and Luster, M. I. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages. Am. J. Respir. Cell Mol. Biol., 12: 676-683, 1995.
12. Janssen, Y. M., Barchowsky, A., Treadwell, M., Driscoll, K. E., and Mossman, B. T. Asbestos induces nuclear factor κ B (NF-κB) DNA-binding activity and NF-κB-dependent gene expression in tracheal epithelial cells. Proc. Natl. Acad. Sci. USA, 92: 8458-8462, 1995.
13. Simeonova, P. P., and Luster, M. I. Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation. Am. J. Respir. Cell Mol. Biol., 15: 787-795, 1996.
14. Fung, H., Quinlan, T. R., Janssen, Y. M., Timblin, C. R., Marsh, J. P., Heintz, N. H., Taatjes, D. J., Vacek, P., Jaken, S., and Mossman, B. T. Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells. Cancer Res., 57: 3101-3105, 1997.
15. Ryseck, R. P., Hirai, S. I., Yaniv, M., and Bravo, R. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (Lond.), 334: 535-537, 1988.
16. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072; 129-157, 1991.
17. Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E., and Leder, P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell, 55: 917-924, 1988.
18. Cohen, D. R., and Curran, T. fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol. Cell Biol., 8: 2063-2069, 1988.
19. Hirai, S. I., Ryseck, R. P., Mechta, F., Bravo, R., and Yaniv, M. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J., 8: 1433-1439, 1989.
20. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., and Karin, M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell, 49: 729-739, 1987.
21. Muller, J. M., Rupee, R. A., and Baeuerle, P. A. Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods, 11: 301-312, 1997.
22. Bernstein, L. R., and Colburn, N. H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science (Washington DC), 244: 566-569, 1989.
23. Barthelman, M., Chen, W., Gensler, H. L., Huang, C., Dong, Z., and Bowden, G. T. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res., 58: 711-716, 1998.
24. McDonnell, S., and Matrisian, L. M. Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev., 9: 305-319, 1990.
25. Crawford, H. C., and Matrisian, L. M. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein, 49: 20-37, 1996.
26. Herr, I., van Dam, H., and Angel, P. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis (Lond.), 15: 1105-1113, 1994.
27. Rincon, M., and Flavell, R. A. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J., 13: 4370-4381, 1994.
28. Huang, C., Ma, W. Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. USA, 94: 5826-5830, 1997.
29. Sun, Y., Dong, Z., Nakamura, K., and Colburn, N. H. Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma. FASEB J., 7: 944-950, 1993.
30. Colburn, N. H., Former, B. F., Nelson, K. A., and Yuspa, S. H. Tumour promoter induces anchorage independence irreversibly. Nature (Lond.), 281: 589-591, 1979.
31. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA, 91: 609-613, 1994.
32. Dong, Z., Huang, C., Brown, R. E., and Ma, W. Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem., 272: 9962-9970, 1997.
33. Huang, C., Ma, W. Y., Hanenberger, D., Cleary, M. P., Bowden, G. T., and Dong, Z. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J. Biol. Chem., 272: 26325-26331, 1997.
34. Li, J. J., Dong, Z., Dawson, M. I., and Colburn, N. H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res., 56: 483-489, 1996.
35. Li, J. J., Westergaard, C., Ghosh, P., and Colburn, N. H. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57: 3569-3576, 1997.
36. Sturgill, T. W., Ray, L. B., Erikson, E., and Maller, J. L. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature (Lond.), 334: 715-718, 1988.
37. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77: 841-852, 1994.
38. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell, 76: 1025-1037, 1994.
39. Bernstein, L. R., Ferris, D. K., Colburn, N. H., and Sobel, M. E. A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator protein-1 transcription factor. J. Biol. Chem., 269: 9401-9404, 1994.
40. Hill, C. S., and Treisman, R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell, 80: 199-211, 1995.
41. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
42. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen- activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270: 27489-27494, 1995.
43. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA, 92: 7686-7689, 1995.
44. Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. J., and Herrlich, P. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell Biol., 7: 2256-2266, 1987.
45. Kerr, L. D., Miller, D. B., and Matrisian, L. M. TGF-β1 inhibition of transin/ stromelysin gene expression is mediated through a Fos binding sequence. Cell, 61: 267-278, 1990.
46. Ye, J., Zhang, X., and Dong, Z. Characterization of the human granulocyte-macrophage colony-stimulating factor gene promoter: an AP1 complex and an Sp1-related complex transactivate the promoter activity that is suppressed by a YY1 complex. Mol. Cell Biol., 16: 157-167, 1996.
47. Foletta, V. C., Segal, D. H., and Cohen, D. R. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukocyte Biol., 63: 139-152, 1998.
48. Dong, Z., Lavrovsky, V., and Colburn, N. H. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis (Lond.), 16: 749-756, 1995.
49. Watts, R. G., Ben-Ari, E. T., Bernstein, L. R., Birrer, M. J., Winterstein, D., Wendel, E., and Colburn, N. H. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation. Mol. Carcinog., 13: 27-36, 1995.
50. Thun, M. J., Namboodiri, M. M., and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer [see comments]. N. Engl. J. Med., 325: 1593-1596, 1991.
51. Narisawa, T., Satoh, M., Sano, M., and Takahashi, T. Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin. Carcinogenesis (Lond.), 4: 1225-1227, 1983.
52. Takahashi, M., Furukawa, F., Toyoda, K., Sato, H., Hasegawa, R., Imaida, K., and Hayashi, Y. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. Carcinogenesis (Lond.), 11: 393-395, 1990.
53. Murasaki, G., Zenser, T. V., Davis, B. B., and Cohen, S. M. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis. Carcinogenesis (Lond.), 5: 53-55, 1984.
54. Sakata, T., Hasegawa, R., Johansson, S. L., Zenser, T. V., and Cohen, S. M. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res., 46: 3903-3906, 1986.
55. Cohen, S. M., Hasegawa, R., Sakata, T., and Johansson, S. L. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Cancer Res., 49: 372-377, 1989.
56. McCormick, D. L., Madigan, M. J., and Moon, R. C. Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res., 45: 1803-1808, 1985.
57. Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell, 80: 225-236, 1995.
58. Whitmarsh, A. J., and Davis, R. J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 74: 589-607, 1996.
59. Payne, D. M., Rossomando, A. J., Martino, P., Erickson, A. K., Her, J. H., Shabanowitz, J., Hunt, D. F., Weber, M. J., and Sturgill, T. W. Identification of the regulatory phosphorylation sites in pp42/mitogen- activated protein kinase (MAP kinase). EMBO J., 10: 885-892, 1991.